Peptide mimics of a tumor antigen induce functional cytotoxic T cells
- PMID: 9528009
- DOI: 10.1038/nbt0398-276
Peptide mimics of a tumor antigen induce functional cytotoxic T cells
Abstract
The ability to mimic peptide/peptide and/or peptide/carbohydrate structures may be important in generating cross-reactive antibodies for autoimmune and other diseases. We show that the peptide sequence DAHWESWL can mimic the conformation of the unrelated MUC1 peptide SAPDTRPAP(G). Mice immunized with mannan-MUC1-peptides make cytotoxic T lymphocytes (CTLs) and are protected from MUC1+ tumors. We show that the same specific anti-MUC1 responses can be produced by immunizing with the DAHWESWL peptide; furthermore, specific tumor protection is obtained in a manner similar to that with MUC1 immunization. The DAHWESWL peptide immunization leads to CTLs that recognize H2Dd and H2Ld but not H2b or human leukocyte antigens-group A (HLA-A) *0201 presented MUC1 peptides. However, mutation of the DAHWESWL peptide to a more HLA-A*0201-compatible structure with appropriate anchors (DLHWASWV), leads to the production of CTLs in HLA-A*0201 mice.
Comment in
-
Mimic 1 of MUC1.Nat Biotechnol. 1998 Mar;16(3):236-7. doi: 10.1038/nbt0398-236. Nat Biotechnol. 1998. PMID: 9527999 No abstract available.
Similar articles
-
Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.Cancer Res. 1994 Oct 1;54(19):5186-93. Cancer Res. 1994. PMID: 7923138
-
Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen.J Immunol. 1997 Dec 1;159(11):5211-8. J Immunol. 1997. PMID: 9548459
-
CTL in mice immunized with human mucin 1 are MHC-restricted.J Immunol. 1995 Dec 1;155(11):5089-94. J Immunol. 1995. PMID: 7594517
-
Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.Important Adv Oncol. 1994:53-69. Important Adv Oncol. 1994. PMID: 8206495 Review. No abstract available.
-
Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.Important Adv Oncol. 1992:61-77. Important Adv Oncol. 1992. PMID: 1374733 Review. No abstract available.
Cited by
-
The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer.Cancers (Basel). 2019 Aug 19;11(8):1205. doi: 10.3390/cancers11081205. Cancers (Basel). 2019. PMID: 31430935 Free PMC article.
-
Targeting antigens to dendritic cell receptors for vaccine development.J Drug Deliv. 2013;2013:869718. doi: 10.1155/2013/869718. Epub 2013 Oct 8. J Drug Deliv. 2013. PMID: 24228179 Free PMC article. Review.
-
Peptide-Drug Conjugates: A New Hope for Cancer Management.Molecules. 2022 Oct 25;27(21):7232. doi: 10.3390/molecules27217232. Molecules. 2022. PMID: 36364057 Free PMC article. Review.
-
Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.Immunology. 2006 Mar;117(3):329-39. doi: 10.1111/j.1365-2567.2005.02304.x. Immunology. 2006. PMID: 16476052 Free PMC article.
-
Structural allele-specific patterns adopted by epitopes in the MHC-I cleft and reconstruction of MHC:peptide complexes to cross-reactivity assessment.PLoS One. 2010 Apr 26;5(4):e10353. doi: 10.1371/journal.pone.0010353. PLoS One. 2010. PMID: 20442757 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous